Vigil Neuroscience, Inc.
(NASDAQ GS: VIGL)
Rigrodsky Law, P.A. is investigating Vigil Neuroscience, Inc. (“Vigil”) regarding possible breaches of fiduciary duties and other violations of law related to Vigil’s agreement to be acquired by Sanofi. Under the terms of the agreement, Vigil shareholders will receive $8.00 per share in cash.